[Pathogenesis of paroxysmal tachycardia in acute myocardial infarct].
D000138:Acidosis / Q000150:complications; D000208:Acute Disease; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D002395:Catecholamines / Q000378:metabolism; D004071:Digitalis Glycosides / Q000009:adverse effects; D004573:Electrolytes / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D000860:Hypoxia / Q000150:complications; D007511:Ischemia / Q000150:complications; D009203:Myocardial Infarction / Q000150:complications* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011802:Quinidine / Q000009:adverse effects; D013614:Tachycardia, Paroxysmal / Q000209:etiology*
D000889:Anti-Arrhythmia Agents; D002395:Catecholamines; D004071:Digitalis Glycosides; D004573:Electrolytes; D005230:Fatty Acids, Nonesterified; D011802:Quinidine; D011188:Potassium; D010100:Oxygen
Patogenia tahicardiilor paroxistice în infarctul miocardic acut